-
Michael J. Fox Foundation Co-Chairs Meeting with FDA to Define Regulatory Path for New Drugs to Treat Cognitive Decline
April 22, 2013
… funded by MJFF have already established the best scale for dyskinesia ). Defining such a common yardstick could help to …
-
Drug Targeting Adenosine Approved for Use in Japan as ‘Adjunctive Therapy for Parkinson’s’
May 30, 2013
… symptomatic benefit for Parkinson’s patients, with less dyskinesias. Merck’s results, however, showed that …
-
Improved Levodopa Delivery Trial Approved for Phase III
October 30, 2014
… overuse is associated with troubling side effects such as dyskinesia . Levodopa is a dopamine replacement therapy; the …
-
Next Generation Parkinson's Disease Treatment through Steering Brain Stimulation (NEXT)
… large reduction of levodopa doses, with levodopa-induced dyskinesias and disability reducing accordingly and improved …
-
Phase I Study of AAV2-hAADC Administered by MRI-guided Real-time Convective Infusion
… potentially reducing the required levodopa dose level and dyskinesias associated with high levodopa administration. …
-
Tracking Mobility and Symptoms of Parkinson's Disease with New Wireless Technology
… that of the Hauser diary, an at-home diary for recording dyskinesia (an abnormal, uncontrolled, involuntary movement …